Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

OLASIMBO M CHIADIKA

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1699825299
CMS profile
895202
Location
HOUSTON, TX

General Payments · PY2018–2024

$29,623.35

  • Reported across 44 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$8,713.20

12 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $91.72 1
PY2019 $1,765.90 3
PY2020 $151.38 4
PY2021 $123.53 2
PY2022 $6,081.90 9
PY2023 $12,695.72 13
PY2024 $8,713.20 12

Payment records · PY2024 (12)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alexion Pharmaceuticals, Inc. $116.15 04/02/2024 Food and Beverage Undisputed 01/23/2026 1094035151 CMS
Amgen Inc. $149.90 02/06/2024 Food and Beverage Undisputed 01/23/2026 1117525999 CMS
Edwards Lifesciences Corporation $40.29 08/28/2024 Food and Beverage Undisputed 01/23/2026 1138851386 CMS
GENZYME CORPORATION $123.92 03/06/2024 Food and Beverage Undisputed 01/23/2026 1139976283 CMS
GENZYME CORPORATION $130.96 09/03/2024 Food and Beverage Undisputed 01/23/2026 1139976315 CMS
Inspire Medical Systems, Inc. $113.06 01/09/2024 Food and Beverage Undisputed 01/23/2026 1148047588 CMS
Inspire Medical Systems, Inc. $127.00 06/12/2024 Food and Beverage Undisputed 01/23/2026 1148047590 CMS
Inspire Medical Systems, Inc. $36.93 09/28/2024 Food and Beverage Undisputed 01/23/2026 1148047592 CMS
PFIZER INC. $3,125.00 02/15/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1131807075 CMS
PFIZER INC. $1,500.00 02/23/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1131807077 CMS
PFIZER INC. $3,125.00 03/12/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1131807079 CMS
Teva Pharmaceuticals USA, Inc. $124.99 07/16/2024 Food and Beverage Undisputed 01/23/2026 1151592843 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.